Position in NTRA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,085
New position
Shares Held
4
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#818
of 844 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Downshift Financial, LLC holds $135,012 across 10 Diagnostics & Research names. NTRA ranks #6 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
194 | $97,263 | |
| 2 | GH |
Guardant Health, Inc.
|
120 | $18,003 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
27 | $14,213 | |
| 4 | DHR |
Danaher Corp /De/
|
9 | $1,714 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
1 | $1,277 | |
| 6 | NTRA |
Natera, Inc.
This page
|
4 | $1,085 | |
| 7 | QGEN |
Qiagen N.V.
|
15 | $586 | |
| 8 | A |
Agilent Technologies, Inc.
|
3 | $398 |
All Filings in NTRA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,085 | 4 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||